19P Resistance Mechanism to First-Line Osimertinib in EGFR-mutated (egfrm) Advanced NSCLC (ansclc) in China: Preliminary Data from FLOURISH Study

J. Zhou, L. Shen,D. Lv,K. Tang, D. Zhu,Y. Zhao, K. Wang, Y. Wang, L. Xing, J. Cui, L. Ding, X. Shi, J. Zheng

ESMO Open（2024）

Cited 0|Views3

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined